Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery
Julia Park, Christopher J. Langmead, Darren Riddy
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 1, pp. 88-106
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
Gabrielle Fredman, Charles N. Serhan
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 808-823
Closed Access | Times Cited: 41
Targeting immune cell recruitment in atherosclerosis
Yvonne Döring, Emiel P. C. van der Vorst, Christian Weber
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 824-840
Closed Access | Times Cited: 18
Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice
Ceren Emre, Luis Enrique Arroyo‐García, Khanh Do, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 42
Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders
Ewelina Honkisz-Orzechowska, Dorota Łażewska, Grzegorz Baran, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1258-1258
Open Access | Times Cited: 15
Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2024) Vol. 96, pp. 102267-102267
Closed Access | Times Cited: 13
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
Ahmad Zaid, Amiram Ariel
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115204-115204
Closed Access | Times Cited: 10
Neuroinflammation, oxidative stress and their interplay in neuropathic pain: Focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies
Luísa Teixeira-Santos, António Albino‐Teixeira, Dora Pinho
Pharmacological Research (2020) Vol. 162, pp. 105280-105280
Closed Access | Times Cited: 60
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
Anandita Pal, Adam H. Metherel, Lauren Fiabane, et al.
Nutrients (2020) Vol. 12, Iss. 12, pp. 3718-3718
Open Access | Times Cited: 50
Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
Tobias Schmid, Bernhard Brüne
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm
Chang Hoon Lee
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 84-98
Open Access | Times Cited: 45
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
Margot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Tanwi Vartak, Catherine Godson, Eoin Brennan
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113965-113965
Open Access | Times Cited: 42
Targeting chronic inflammation as a potential adjuvant therapy for osteoporosis
Gregory Livshits, Alexander Kalinkovich
Life Sciences (2022) Vol. 306, pp. 120847-120847
Closed Access | Times Cited: 35
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35
Cheng Xue Qin, Lucy V. Norling, Elizabeth A. Vecchio, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 19, pp. 4617-4639
Open Access | Times Cited: 34
Molecular Actors of Inflammation and Their Signaling Pathways: Mechanistic Insights from Zebrafish
Jade Leiba, Resul Özbilgiç, Liz Hernández, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 153-153
Open Access | Times Cited: 20
Pro-resolving metabolites: Future of the fish oil supplements
Asma Maliha, Maisha Tahsin, Tayeba Zaman Fabia, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106439-106439
Open Access | Times Cited: 6
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor
Mohamad Wessam Alnouri, Kenneth Anthony Roquid, Rémy Bonnavion, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 6
Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice
Myles R. McCrary, Michael Qize Jiang, Michelle M. Giddens, et al.
The FASEB Journal (2019) Vol. 33, Iss. 10, pp. 10680-10691
Open Access | Times Cited: 52
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Paula Morales, Ana Lago-Fernandez, Dow P. Hurst, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14216-14227
Open Access | Times Cited: 44
Adenosine and inflammation: it's time to (re)solve the problem
Luca Antonioli, Pál Pacher, György Haskó
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 43-55
Closed Access | Times Cited: 37
Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
Yong‐Hyun Han, Lee KyeongJin, Abhirup Saha, et al.
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 5, pp. 455-464
Open Access | Times Cited: 31
The diverse roles of TMEM16A Ca2+-activated Cl− channels in inflammation
Weiliang Bai, Mei Liu, Qinghuan Xiao
Journal of Advanced Research (2021) Vol. 33, pp. 53-68
Open Access | Times Cited: 27
The challenges of treating osteoarthritis pain and opportunities for novel peripherally directed therapeutic strategies
Sara Gonçalves, Peter R.W. Gowler, Stephen G. Woodhams, et al.
Neuropharmacology (2022) Vol. 213, pp. 109075-109075
Open Access | Times Cited: 21
Neutrophil Immunomodulatory Activity of Farnesene, a Component of Artemisia dracunculus Essential Oils
Igor A. Schepetkin, Gülmira Özek, Т. Оzеk, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 642-642
Open Access | Times Cited: 20
Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target
Andrew A. Bolinger, Andrew Frazier, Jun‐Ho La, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3318-3334
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top